Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Leishmaniasis; Leishmaniasis, Cutaneous Phase 2 ClinicalTrials
Leishmaniasis; Leishmaniasis, Mucocutaneous Phase 2/Phase 3 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 2 ClinicalTrials
Leishmaniasis; Leishmaniasis, Mucocutaneous Phase 2 ClinicalTrials
Leishmaniasis; Leishmaniasis, Visceral Phase 4 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 3 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 3 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 3 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 4 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 2/Phase 3 ClinicalTrials
Leishmaniasis; Leishmaniasis, Cutaneous Phase 4 ClinicalTrials
CONTENTS